Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk

Nutrition

Volumn 27, Issue 9, 2011, Pages 912-918

  Yeon, Jee Young ^a   Suh, Young Jin ^b   Kim, Sang Wook ^c   Baik, Hyun Wook ^c   Sung, Chung Ja ^a   Kim, Hyun Sook ^a   Sung, Mi Kyung ^a  

^a Sookmyung Women's University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Bundang Jesaeng Hospital   (South Korea)

Author keywords

Antioxidant capacity; Antioxidant vitamins; Food frequency questionnaire; Mammary tumors; Proinflammatory cytokines

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RETINOL; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RECURRENCE; CANCER RISK; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN INTAKE;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DEOXYGUANOSINE; DIET; DIET SURVEYS; DIETARY CARBOHYDRATES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MIDDLE AGED; OXIDATIVE STRESS; QUESTIONNAIRES; RISK FACTORS; VITAMIN A; VITAMINS;

EID: 79960783609     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2010.10.012     Document Type: Article

References (61)

1. The Ministry of Health, Welfare and Family Affairs of Korea/National Cancer Control Institute, Division of Cancer Statistics and Registry. Annual report on national cancer incidence statistics. 2008.
2. Benz C.C., Atsriku C., Yau C., Britton D., Schilling B., Gibson B.W., et al. Novel pathways associated with quinone-induced stress in breast cancer cells. Drug Metab Rev 2006, 38:601-613.
3. Malins D.C., Anderson K.M., Jaruga P., Ramsey C.R., Gilman N.K., Green V.M., et al. Oxidative changes in the DNA of stroma and epithelium from the female breast: potential implications for breast cancer. Cell Cycle 2006, 5:1629-1632.
4. Huang Y.L., Sheu J.Y., Lin T.H. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem 1999, 32:131-136.
5. Musarrat J., Arezina-Wilson J., Wani A.A. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 1996, 32A:1209-1214.
6. Cerutti P.A. Prooxidant states and tumor promotion. Science 1985, 227:375-381.
7. Olinski R., Gackowski D., Foksinski M., Rozalski R., Roszkowski K., Jaruga P. Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 2002, 33:192-200.
8. Jackson J.H. Potential molecular mechanisms of oxidant-induced carcinogenesis. Environ Health Perspect 1994, 102:155-157.
9. Mannello F., Tonti G.A., Pagliarani S., Benedetti S., Canestrari F., Zhu W., et al. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer. Int J Cancer 2007, 120:1971-1976.
10. Sener D.E., Gonenc A., Akinci M., Torun M. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 2007, 25:377-382.
11. Gonenc A., Ozkan Y., Torun M., Simsek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther 2001, 26:141-144.
12. Khanzode S.S., Muddeshwar M.G., Khanzode S.D., Dakhale G.N. Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic Res 2004, 38:81-85.
13. Fam S.S., Morrow J.D. The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 2003, 10:1723-1740.
14. Morrow J.D. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 2000, 32:377-385.
15. Trush M.A., Kensler T.W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic Biol Med 1991, 10:201-209.
16. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119:529-542.
17. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
18. Youngs S.J., Ali S.A., Taub D.D., Rees R.C. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997, 71:257-266.
19. Azenshtein E., Luboshits G., Shina S., Neumark E., Shahbazian D., Weil M., et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 2002, 62:1093-1102.
20. Kim E.-Y., Jeon H.-M., Sung M.-K., Sung C.-J. Comparisons of food intake between breast cancer patients and controls in Korean women. Nutr Res Pract 2007, 1:237-242.
21. Dillon S.A., Lowe G.M., Billington D., Rahman K. Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F(2 alpha) in smoking and nonsmoking men and women. J Nutr 2002, 132:168-171.
22. Bae S.C., Jung W.J., Lee E.J., Yu R., Sung M.K. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr 2009, 28:56-62.
23. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007. p. 292-293.
24. Carmichael A.R., Bates T. Obesity and breast cancer: a review of the literature. Breast 2004, 13:85-92.
25. Saquib N., Flatt S.W., Natarajan L., Thomson C.A., Bardwell W.A., Caan B., et al. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the Women's Healthy Eating and Living (WHEL) study. Breast Cancer Res Treat 2007, 105:177-186.
26. Judd H.L., Shamonki I.M., Frumar A.M., Lagasse L.D. Origin of serum estradiol in postmenopausal women. Obstet Gynecol 1982, 59:680-686.
27. Cirillo D., Rachiglio A.M., la Montagna R., Giordano A., Normanno N. Leptin signaling in breast cancer: an overview. J Cell Biochem 2008, 105:956-964.
28. Vincent H.K., Taylor A.G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006, 30:400-418.
29. Loft S., Moller P., Cooke M.S., Rozalski R., Olinski R. Antioxidant vitamins and cancer risk: is oxidative damage to DNA a relevant biomarker?. Eur J Nutr 2008, 47:19-28.
30. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995, 358:1-3.
31. Kasapovic J., Pejic S., Todorovic A., Stojiljkovic V., Pajovic S.B. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 2008, 26:723-730.
32. Liu X., Zhao J., Zheng R. DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat Res 2003, 539:1-8.
33. Ching S., Ingram D., Hahnel R., Beilby J., Rossi E. Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study. J Nutr 2002, 132:303-306.
34. Michels K.B., Mohllajee A.P., Roset-Bahmanyar E., Beehler G.P., Moysich K.B. Diet and breast cancer: a review of the prospective observational studies. Cancer 2007, 109:2712-2749.
35. Ray G., Batra S., Shukla N.K., Deo S., Raina V., Ashok S., Husain S.A. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 2000, 59:163-170.
36. Pratico D., Barry O.P., Lawson J.A., Adiyaman M., Hwang S.W., Khanapure S.P., et al. IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A 1998, 95:3449-3454.
37. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994, 305:253-264.
38. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
39. Hussein M.Z., Al Fikky A., Abdel Bar I., Attia O. Serum IL-6 and IL-12 levels in breast cancer patients. Egypt J Immunol 2004, 11:165-170.
40. Zakrzewska I., Kozlowski L., Wojtukiewicz M. [Assessment of changes in levels of interleukin 6 and C reactive protein in patients with breast tumors]. Pol Merkur Lekarski 2003, 15:115-117.
41. Kozlowski L., Zakrzewska I., Tokajuk P., Wojtukiewicz M.Z. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst 2003, 48:82-84.
42. Ahmed O.I., Adel A.M., Diab D.R., Gobran N.S. Prognostic value of serum level of interleukin-6 and interleukin-8 in metastatic breast cancer patients. Egypt J Immunol 2006, 13:61-68.
43. Nicolini A., Carpi A., Rossi G. Cytokines in breast cancer. Cytokine Growth Factor Rev 2006, 17:325-337.
44. Pantschenko A.G., Pushkar I., Anderson K.H., Wang Y., Miller L.J., Kurtzman S.H., et al. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 2003, 23:269-284.
45. Honma S., Shimodaira K., Shimizu Y., Tsuchiya N., Saito H., Yanaihara T., Okai T. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J 2002, 49:371-377.
46. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
47. Cho J.J., Koh E.Y., Song Y.M., Han B.K., Yun Y.S., Park H.A., et al. Mammographic breast density and risk factors of breast cancer in Korean women using multicenter study. J Korean Acad Fam Med 2006, 27:33-41.
48. Boyd N.F., Dite G.S., Stone J., Gunasekara A., English D.R., McCredie M.R., et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002, 347:886-894.
49. Kallio P., Kolehmainen M., Laaksonen D.E., Pulkkinen L., Atalay M., Mykkanen H., et al. Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome. Am J Clin Nutr 2008, 87:1497-1503.
50. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000, 85:2970-2973.
51. Aljada A., Mohanty P., Ghanim H., Abdo T., Tripathy D., Chaudhuri A., Dandona P. Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 2004, 79:682-690.
52. Lopez-Garcia E., Schulze M.B., Fung T.T., Meigs J.B., Rifai N., Manson J.E., Hu F.B. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004, 80:1029-1035.
53. Lee E.-J., Lee W.-K., Suh S., Suh B.-H., Lee H.-S. Intakes of energy and nutrients and risk of breast cancer. Korean J Nutr 2008, 41:754-766.
54. Martin-Moreno J.M., Willett W.C., Gorgojo L., Banegas J.R., Rodriguez-Artalejo F., Fernandez-Rodriguez J.C., et al. Dietary fat, olive oil intake and breast cancer risk. Int J Cancer 1994, 58:774-780.
55. Zhao G., Etherton T.D., Martin K.R., Gillies P.J., West S.G., Kris-Etherton P.M. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr 2007, 85:385-391.
56. Valtuena S., Pellegrini N., Franzini L., Bianchi M.A., Ardigo D., Del Rio D., et al. Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr 2008, 87:1290-1297.
57. Freudenheim J.L., Marshall J.R., Vena J.E., Laughlin R., Brasure J.R., Swanson M.K., et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996, 88:340-348.
58. Sweetman S.F., Strain J.J., McKelvey-Martin V.J. Effect of antioxidant vitamin supplementation on DNA damage and repair in human lymphoblastoid cells. Nutr Cancer 1997, 27:122-130.
59. Thompson H.J., Heimendinger J., Haegele A., Sedlacek S.M., Gillette C., O'Neill C., et al. Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. Carcinogenesis 1999, 20:2261-2266.
60. Kim H.Y., Kim O.H., Sung M.K. Effects of phenol-depleted and phenol-rich diets on blood markers of oxidative stress, and urinary excretion of quercetin and kaempferol in healthy volunteers. J Am Coll Nutr 2003, 22:217-223.
61. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Wang G.Q., et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993, 85:1483-1492.